NCT01617824View on ClinicalTrials.gov

Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Type 2 DiabetesChronic Renal Failure
Interventions
DRUG

Linagliptin

Linagliptin 5 mg tablets for 4 days

DRUG

Placebo

Placebo tablets for 4 days

Trial Locations (1)

35100

University Hospital Diabetes Outpatient Clinic, Padua

All Listed Sponsors
lead

University of Padova

OTHER

NCT01617824 - Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetes | Biotech Hunter | Biotech Hunter